Electrolyte State in Patients With COVID-19

Status Completed

Clinical Trial Summary

Initial case reports and cohort studies have described many clinical characteristics of patients with coronavirus disease 2019 (COVID-19), an emerging infectious disorder caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In early COVID-19 studies, some evidence has been provided that electrolyte disorders may also be present upon patients' presentation, including sodium, potassium, chloride and calcium abnormalities the aim of the study is Identification of elements that affect COVID-19 pathology to improve survival and decrease mortality rate.

Clinical Trial Description

SARS-CoV-2 invades human cells through binding angiotensin I converting enzyme 2 (ACE2) on the cell membrane. ACE2 is widely distributed in many types of human tissues, especially in the vital organs, such as heart, liver, kidney, and lungs. ACE2 is viewed as the principal counter-regulatory mechanism for the main axis of renin-angiotensin system (RAS) that is an essential player in the control of blood pressure and electrolyte balance. The final effect is to increase reabsorption of sodium and water, and thereafter increase blood pressure and excretion of potassium (K+). Besides, patients with COVID-19 often had gastrointestinal symptoms such as diarrhea and vomiting Early studies proved that high percentage of COVID-19 patient were presented with electrolyte disorders, including sodium, potassium, chloride and calcium abnormalities. Such electrolyte disturbances have important implications not only for patient management but also for identifying potential pathophysiologic mechanisms underlying COVID-19 that could drive novel therapeutic opportunities ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04539834
Study type	Observational
Source	Zagazig University
Contact
Status	Completed
Phase
Start date	May 1, 2020
Completion date	October 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06097104` - Electrolytes Disturbances in Critically Ill Egyptian Patients
Recruiting	`NCT05768789` - Buoy Electrolyte Study on Hydration Status of Active Men and Women	N/A
Recruiting	`NCT06036823` - 5 Versus 10 Units of Insulin in Hyperkalemia Management	Phase 4
Not yet recruiting	`NCT06030609` - The Comparison Between Ringer Lactate Solution and Normal Saline in Post-Operative Period of Kidney Transplantation	Phase 3
Completed	`NCT05550467` - 24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease
Recruiting	`NCT05595395` - The Enteral Resuscitation In Intensive Care Pilot- Study	N/A
Completed	`NCT05052463` - Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study